Clinical Trials - PRGO

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT06057506Comparative Study for the Evaluation of Two Medical Devices on the Treatment of Head Lice InfestationUNKNOWNNA2023-08-212023-112023-11
NCT05379114Comparative Study for the Evaluation of a New Medical Device on the Treatment of Head Lice InfestationUNKNOWNNA2022-05-182022-092022-07
NCT04749784Effects of Arterin Cholesterol for Reduction of Lipid LevelsUNKNOWNNA2020-10-302021-062021-06
NCT04086797DBRPC Study to Evaluate the Efficacy and Safety of IQP-AE-103 in Overweight and Moderately Obese SubjectsCOMPLETEDNA2019-09-112021-04-082021-04-08
NCT02317952Formula for Children With Cow's Milk AllergyCOMPLETEDNA2014-052016-122016-07
NCT01744106A Multicenter Study of Pseudoephedrine for the Temporary Relief of Nasal Congestion in Children With the Common ColdCOMPLETEDPHASE32012-112016-042016-04
NCT01497314Growth and Safety of a Low Lactose Milk-Based Infant FormulaCOMPLETEDNA2011-122013-032013-03
NCT00938483Tolerability and Safety of An Infant FormulaCOMPLETEDNA2007-082009-012008-09
NCT00936637Effects on Growth of an Extensively Hydrolyzed Formula Fed to TermCOMPLETEDNA2007-072008-122008-12
NCT00803764Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fed ConditionsCOMPLETEDPHASE12004-062004-07
NCT00804401Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12004-062004-07
NCT00802828Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fasting ConditionsCOMPLETEDPHASE12004-062004-06
NCT00803192Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fed ConditionsCOMPLETEDPHASE12004-062004-06
NCT00804440Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fasting ConditionsCOMPLETEDPHASE12004-012004-01
NCT00803946Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fed ConditionsCOMPLETEDPHASE12003-112003-11